Screener
Kestra Medical Technologies KMTS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Refund of deposits for medical rental equipment | 184 | 283 |
| Investment in equity security | (5,000) | — |
| Purchase of marketable securities | (163,041) | — |
| Net cash used in investing activities | (203,277) | (23,308) |
| Cash flows from financing activities | ||
| Proceeds from issuance of redeemable preferred stock | — | 103,400 |
| Proceeds from issuance of common stock | 149,291 | 215,789 |
| Proceeds from issuance of stock to non-controlling interest | — | 17,100 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's investing cash flow?
- Kestra Medical Technologies (KMTS) reported investing cash flow of -$172.71M in Q1 2026.
- How has Kestra Medical Technologies's investing cash flow changed year-over-year?
- Kestra Medical Technologies's investing cash flow decreased by 2232.6% year-over-year, from -$7.4M to -$172.71M.
- What is the long-term trend for Kestra Medical Technologies's investing cash flow?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's investing cash flow has grown at a 307.7% compound annual growth rate (CAGR), from -$12.23M to -$203.28M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Kestra Medical Technologies's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude